Abstract

Regeneration of cardiac muscle has been the ultimate objective of cell-based therapy over the last decade. The first generation of clinical stem cell trials in cardiology, however, have borne only modest success, such that the regeneration of mature cardiomyocytes remains elusive ([1][1]). Rather,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call